Phase i open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): Study protocol
Research output: Contribution to journal › Article › peer-review
7Citations
(Scopus)
31Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Phase i open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): Study protocol'. Together they form a unique fingerprint.